by Jake Ciszewski | Jan 10, 2024
Robin Kate Kelley, MD, Professor of Clinical Medicine Hematology/IOncology, University of California, San Francisco, describes the need for better treatment plans for patients with biliary tract cancer. Transcription: Interestingly, the perihelia and distal...
by Jake Ciszewski | Jan 7, 2024
Tuan Vu, MD Department of Neurology, University at Tampa Florida, discusses the ADAPT-SC study for the treatment of patients with generalized myasthenia gravis (gMG) Transcription: As this turns out, the efficacy seems almost equal. Then you look at the results,...
by Jake Ciszewski | Jan 6, 2024
Robin Kate Kelley, professor of clinical medicine in the division of hematology/oncology, University of California, San Francisco, dissects biliary tract cancer. Transcription: My name is Katie Kelley, and I’m a GI Medical Oncologist at the University of...
by Jake Ciszewski | Jan 5, 2024
Kim Moran, SVP, head of U.S. Rare Diseases, discusses new treatments being approved by the FDA to combat myasthenia gravis. Transcription Hi, I’m Kim Moran. I am the Head of U.S. Rare Disease for the US, for UCB. I get to help people living with rare diseases...
by Jake Ciszewski | Jan 4, 2024
Björn Mellgård, MD, PhD, Vice President, Global Program Lead, Rare Genetics and Hematology, Takeda, discusses Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Transcription: My name is Björn Mellgård. As you may understand from that name, I’m from...
